Skip to main content

Series B Pharmaceutical Companies

Explore 128 pharmaceutical startups that raised series b funding. Access verified founder contact information and fundraising data.

Total Companies
128
Total Funding
$1.2B
Avg Funding
$47.2M
Cities
23

Export 128 Series B Pharmaceutical Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Tel Aviv, Israel
$80.0M
raised

CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.

Jul 2024
Series B

Founder Contacts

30,000+ verified contacts

$10.0M
raised

A leading EU-GMP European vertically integrated Multi-Country Operator company with a global footprint

Jul 2024
Series B

Founder Contacts

30,000+ verified contacts

Genive, Switzerland
$85.7M
raised

iOnctura is a clinical-stage biotechnology company that specializes in developing treatments for cancer.

Jun 2024
Series B

Founder Contacts

30,000+ verified contacts

Cincinnati, United States
$73.0M
raised

CinRx Pharma develops therapies for unmet needs, leveraging partnerships and expertise to advance new molecular entities.

May 2024
Series B

Founder Contacts

30,000+ verified contacts

Fishers, United States
$42.9M
raised

INCOG BioPharma services include injectable drug product formulation, analytical method, process scale up, and formulation.

May 2024
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 128 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Ness Ziona, Israel
$17.5M
raised

DOT Compliance delivers the industry's first ready to use cloud-based quality and compliance management solution for regulated industries.

Apr 2024
Series B

Founder Contacts

30,000+ verified contacts

San Diego, United States
$132.0M
raised

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

Apr 2024
Series B

Founder Contacts

30,000+ verified contacts

Seattle, United States
$4.7M
raised

Proniras focuses on development of a new parenteral medical countermeasure (MCM) to treat seizures and brain injury.

Feb 2024
Series B

Founder Contacts

30,000+ verified contacts

Concord, United States
$75.0M
raised

Our purpose is to make every pregnancy around the world safer.

Jan 2024
Series B

Founder Contacts

30,000+ verified contacts

Manchester, United Kingdom
$23.2M
raised

Holiferm develops holistically improved fermentation technology for massive economic improvements.

Dec 2023
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 128 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Philadelphia, United States
$41.5M
raised

Aro Biotherapeutics develops tissue-targeted genetic medicines using Centyrins, a proprietary technology, to address complex diseases.

Nov 2023
Series B

Founder Contacts

30,000+ verified contacts

Risskov, Denmark
$81.4M
raised

NMD Pharma is a small molecule drug discovery company that develops novel treatments of neuromuscular disorders.

Nov 2023
Series B

Founder Contacts

30,000+ verified contacts

Pittsburgh, United States
$20.0M
raised

Free Market Health is a healthcare technology company empowering payers and pharmacies with a care-driven marketplace platform.

Nov 2023
Series B

Founder Contacts

30,000+ verified contacts

Clonmel, Ireland
$35.0M
raised

Shorla Pharma is an Irish specialty pharmaceutical company.

Oct 2023
Series B

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$72.0M
raised

ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.

Sep 2023
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 128 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Cambridge, United States
$6.0M
raised

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain injury patients.

Aug 2023
Series B

Founder Contacts

30,000+ verified contacts

London, United Kingdom
$60.0M
raised

Causaly develops a biomedical research discovery tool designed to find and unlock key hidden evidence in biomedicine.

Jul 2023
Series B

Founder Contacts

30,000+ verified contacts

Cambridge, United States
$150.0M
raised

Alkeus Pharmaceuticals is a Boston-based startup focused on treatments for serious ophthalmic conditions.

Jun 2023
Series B

Founder Contacts

30,000+ verified contacts

Oxford, United Kingdom
$12.5M
raised

OMass Therapeutics is a drug discovery company exploiting novel mass spectrometry platforms to develop therapeutics.

May 2023
Series B

Founder Contacts

30,000+ verified contacts

Suresnes, France
$21.5M
raised

AlgoTherapeutix is the operator of a biotechnology company designed to develop topical treatments for complex pain.

Mar 2023
Series B

Founder Contacts

30,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 128 funded startups

30,000+ verified emails
Unlimited exports
No credit card required
Natick, United States
$50.0M
raised

Allorion Therapeutics is a small molecule therapeutic development company that focuses on cancer and autoimmune illnesses.

Mar 2023
Series B

Founder Contacts

30,000+ verified contacts

Singapore, Singapore
$10.0M
raised

SwipeRx is a developer of a medical technology platform designed to connect pharmaceutical manufacturers, pharmacies, and patients.

Feb 2023
Series B

Founder Contacts

30,000+ verified contacts

San Mateo, United States

Revagenix is a biopharmaceutical company discovering and developing therapies to address medical needs.

Jan 2024
Series B

Founder Contacts

30,000+ verified contacts

Corte Madera, United States
$37.0M
raised

Ophirex is developing affordable, accessible, oral treatments to snakebite.

Jan 2023
Series B

Founder Contacts

30,000+ verified contacts

New Haven, United States
$40.0M
raised

Simcha Therapeutics is a biopharmaceutical company developing engineered cytokine immunotherapy for cancer.

Jan 2022
Series B

Founder Contacts

30,000+ verified contacts

Showing 76 to 100 of 128 companies

Ready to Connect with Series B Pharmaceutical Startups?

Get verified founder emails, funding details, and company data for 128 series b pharmaceutical companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked

128 Pharmaceutical Series B Startups (August 2026) — Page 4 | VCBacked